Search Results - "Gauler, Thomas C." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

by Escudier, Bernard, Sharma, Padmanee, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Gurney, Howard, Donskov, Frede, Peltola, Katriina, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Zhao, Huanyu, Waxman, Ian M, Motzer, Robert J
Published in European urology (01.12.2017)

Get full text

Journal Article

Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients

Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients

by Breitenbuecher, Frank, Hoffarth, Sandra, Worm, Karl, Cortes-Incio, Diana, Gauler, Thomas C, Köhler, Jens, Herold, Thomas, Schmid, Kurt Werner, Freitag, Lutz, Kasper, Stefan, Schuler, Martin
Published in PloS one (21.01.2014)

Get full text

Journal Article

Circulating Tumor Cell Composition in Renal Cell Carcinoma

Circulating Tumor Cell Composition in Renal Cell Carcinoma

by Nel, Ivonne, Gauler, Thomas C, Bublitz, Kira, Lazaridis, Lazaros, Goergens, André, Giebel, Bernd, Schuler, Martin, Hoffmann, Andreas-Claudius
Published in PloS one (21.04.2016)

Get full text

Journal Article

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab

by Pogorzelski, Michael, Hilser, Thomas, Ting, Saskia C., Kansy, Benjamin, Gauler, Thomas C., Stuschke, Martin, Schmid, Kurt W., Lang, Stephan, Grünwald, Viktor, Schuler, Martin, Kasper, Stefan
Published in Frontiers in oncology (13.05.2021)

Get full text

Journal Article

Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104

Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104

by Kruger, Stephan, Boeck, Stefan, Heinemann, Volker, Laubender, Ruediger P., Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C., Fischer von Weikersthal, Ludwig, Clemens, Michael R., Geissler, Michael, Greten, Tim F., Hegewisch-Becker, Susanna, Modest, Dominik P., Stintzing, Sebastian, Haas, Michael
Published in Acta oncologica (01.07.2015)

Get full text

Journal Article

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

by Motzer, Robert J., Escudier, Bernard, George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Plimack, Elizabeth R., Procopio, Giuseppe, McDermott, David F., Castellano, Daniel, Choueiri, Toni K., Donskov, Frede, Gurney, Howard, Oudard, Stéphane, Richardet, Martin, Peltola, Katriina, Alva, Ajjai S., Carducci, Michael, Wagstaff, John, Chevreau, Christine, Fukasawa, Satoshi, Tomita, Yoshihiko, Gauler, Thomas C., Kollmannsberger, Christian K., Schutz, Fabio A., Larkin, James, Cella, David, McHenry, M. Brent, Saggi, Shruti Shally, Tannir, Nizar M.
Published in Cancer (15.09.2020)

Get full text

Journal Article

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

by Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee
Published in The New England journal of medicine (05.11.2015)

Get full text

Journal Article

$An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck$

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck

by Saloura, Vassiliki, Cohen, Ezra E. W., Licitra, Lisa, Billan, Salem, Dinis, Jose, Lisby, Steen, Gauler, Thomas C.
Published in Cancer chemotherapy and pharmacology (01.06.2014)

Get full text

Journal Article

HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells

HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells

by Kansy, Benjamin A., Wehrs, Tim P., Bruderek, Kirsten, Si, Yu, Ludwig, Sonja, Droege, Freya, Hasskamp, Pia, Henkel, Uta, Dominas, Nina, Hoffmann, Thomas K., Horn, Peter A., Schuler, Martin, Gauler, Thomas C., Lindemann, Monika, Lang, Stephan, Bankfalvi, Agnes, Brandau, Sven
Published in Cancer Immunology, Immunotherapy (01.12.2023)

Get full text

Journal Article

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

by Heinemann, Volker, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C, von Weikersthal, Ludwig Fischer, Clemens, Michael R, Geissler, Michael, Greten, Tim F, Hegewisch-Becker, Susanna, Rubanov, Oleg, Baake, Gerold, Höhler, Thomas, Ko, Yon D, Jung, Andreas, Neugebauer, Sascha, Boeck, Stefan
Published in Gut (01.05.2013)

Get full text

Journal Article

Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck

Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck

by Harbeck, Nadia, Solca, Flavio, Gauler, Thomas C
Published in Future oncology (London, England) (01.01.2014)

Get full text

Journal Article

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

by Christoph, Daniel C., Asuncion, Bernadette Reyna, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D., O’Shannessy, Daniel J., Wynes, Murry W., Gauler, Thomas C., Wohlschlaeger, Jeremias, Hoiczyk, Mathias, Schuler, Martin, Eberhardt, Wilfried E., Hirsch, Fred R.
Published in Journal of thoracic oncology (01.01.2013)

Get full text

Journal Article

Erratum to “CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962–71]

Erratum to “CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962–71]

by Escudier, Bernard, Sharma, Padmanee, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellano, Daniel, Gurney, Howard, Donskov, Frede, Peltola, Katriina, Wagstaff, John, Gauler, Thomas C., Ueda, Takeshi, Zhao, Huanyu, Waxman, Ian M., Motzer, Robert J.
Published in European urology (01.04.2018)

Get full text

Journal Article

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

by Ormanns, Steffen, Siveke, Jens T, Heinemann, Volker, Haas, Michael, Sipos, Bence, Schlitter, Anna Melissa, Esposito, Irene, Jung, Andreas, Laubender, Rüdiger P, Kruger, Stephan, Vehling-Kaiser, Ursula, Winkelmann, Cornelia, Fischer von Weikersthal, Ludwig, Clemens, Michael R, Gauler, Thomas C, Märten, Angela, Geissler, Michael, Greten, Tim F, Kirchner, Thomas, Boeck, Stefan
Published in BMC cancer (28.08.2014)

Get full text

Journal Article

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

by Christoph, Daniel C., Asuncion, Bernadette Reyna, Mascaux, Celine, Tran, Cindy, Lu, Xian, Wynes, Murry W., Gauler, Thomas C., Wohlschlaeger, Jeremias, Theegarten, Dirk, Neumann, Volker, Hepp, Rodrigo, Welter, Stefan, Stamatis, Georgios, Tannapfel, Andrea, Schuler, Martin, Eberhardt, Wilfried E., Hirsch, Fred R.
Published in Journal of thoracic oncology (01.09.2012)

Get full text

Journal Article

Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours

Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours

by Trarbach, Tanja, Schultheis, Beate, Gauler, Thomas C., Schneider, Vesile, Strumberg, Dirk, Eberhardt, Wilfried E. E., Le Scouiller, Stephanie, Marotti, Marcelo, Brown, Kathryn H., Drevs, Joachim
Published in Investigational new drugs (01.10.2012)

Get full text

Journal Article

Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients

Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients

by Christoph, Daniel C, Reyna-Asuncion, Bernadette, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D, O'Shannessy, Daniel J, Gauler, Thomas C, Wohlschlaeger, Jeremias, Schuler, Martin, Eberhardt, Wilfried E, Hirsch, Fred R
Published in Clinical lung cancer (01.09.2014)

Get full text

Journal Article

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer

by Nensa, Felix, Stattaus, Jörg, Morgan, Bruno, Horsfield, Mark A, Soria, Jean-Charles, Besse, Benjamin, Gounant, Valerie, Khalil, Antoine, Seng, Katja, Fischer, Berthold, Krissel, Heiko, Laurent, Dirk, Christoph, Daniel, Eberhardt, Wilfried EE, Gauler, Thomas C
Published in Future oncology (London, England) (01.04.2014)

Get full text

Journal Article

Behandlungsrealität des kleinzelligen Lungenkarzinoms in Deutschland – das CRISP-Register

Behandlungsrealität des kleinzelligen Lungenkarzinoms in Deutschland – das CRISP-Register

by Sebastian, Martin, Fischer, Rieke N., Reck, Martin, Binninger, Adrian, Hipper, Annette, Gauler, Thomas C., Waller, Cornelius F.
Published in Der Onkologe (01.09.2021)

Get full text

Journal Article

Detection of Circulating Lung Cancer Cells with Strong Thymidylate Synthase Reactivity in the Peripheral Blood of a Patient with Pulmonary Adenocarcinoma Treated with Pemetrexed

Detection of Circulating Lung Cancer Cells with Strong Thymidylate Synthase Reactivity in the Peripheral Blood of a Patient with Pulmonary Adenocarcinoma Treated with Pemetrexed

by Christoph, Daniel C., Hoffmann, Andreas-Claudius, Gauler, Thomas C., Asuncion, Bernadette Reyna, Loewendick, Heike, Peglow, Anja, Hassan, Biftu, Tran, Cindy, Wynes, Murry W., Schuler, Martin, Eberhard, Wilfried E., Hirsch, Fred R.
Published in Journal of thoracic oncology (01.04.2012)

Get full text

Journal Article